EN | UA
EN | UA

Help Support

Back

News

# Trending Topics

  • Trial compares 1% Terbinafine vs 1% Clotrimazole C...

    A randomized controlled trial showed that for Tinea pedis (athletic foot) management, 1 week Terbinafine twice a day is as effective as 4 weeks C...

    More details
  • Paracetamol vs Ibuprofen. Which is better for trea...

    In a systematic review and meta-analysis, both Paracetamol and Ibuprofen demonstrated superior effectiveness compared to a placebo in addressing...

    More details
  • Study reveals the effect of Isotretinoin on menstr...

    Novel findings from a recent prospective observational study shed light on the impact of oral intake of Isotretinoin on menstrual cycles among ac...

    More details
  • Tirzepatide injection gets FDA approval for chroni...

    According to the notification published on 8 Nov 2023, the United States Food and Drug Administration (US-FDA) has authorized Tirzepatide injecti...

    More details
  • Study assesses efficacy of ketorolac for treatment...

    In people presenting with migraine headache, ketorolac might have similar effectiveness when compared to phenothiazines and metoclopramide for mi...

    More details
  • Is alcohol safe for rheumatoid arthritis patients...

    Rheumatoid Arthritis (RA) patients taking Methotrexate (MTX) are often advised to decrease their alcohol intake due to the increased risk of hepa...

    More details
  • Does exercise induce GERD or relieve acid reflux?...

    Different factors are accountable for the impact of exercise or physical activity on the onset of gastroesophageal reflux disease (GERD), a sessi...

    More details
  • GERD Symptoms: Could Intermittent Fasting Help?

    A study published in the "Journal of Clinical Gastroenterology" showed symptomatic relief in gastroesophageal reflux disease (GERD) sym...

    More details
  • Understanding bleeding patterns associated with ea...

    A recent study published in the Maternal-Fetal Medicine Journal found that terminated bleeding after 2 weeks is a predictive indicator for effe...

    More details
  • Leaning right is most effective position while swa...

    According to new research, a person's posture can affect how quickly a pill enters the intestines by as much as 83%. The best posture was to...

    More details

News

Medical News
See All
99
Medical News

Structured exercise eases foot pain and improves mobility in rheu...

Supervised exercise programs reduce foot pain and improve physical function in adults with rheumatoid arthritis, with aquatic exercise, Tai Chi,...

111
Medical News

PCOS-associated acne treatment differs across racial and ethnic g...

Adolescents with PCOS-related acne experience notable racial differences in dermatologic treatment, particularly in access to hormonal and advanc...

107
Medical News

Pathogenic Malassezia variants linked to recurrent fungal skin co...

Clinical isolates of Malassezia furfur associated with pityriasis versicolor demonstrate heightened biofilm production and stronger environmental...

125
Medical News

New study maps best treatments for mental health symptoms in PCOS...

Emotion-focused therapy, peer support, omega-3 plus vitamin E, and mindfulness stress management improve anxiety and depression outcomes in PCOS,...

84
Medical News

Joint-preserving knee surgery shows strong 12-month benefits in m...

Proximal fibular osteotomy improves pain, knee function, joint space width, and varus alignment at 12 months in patients with medial compartment...

74
Medical News

E2/DYD therapy outperforms dydrogesterone alone for perimenopausa...

Estradiol–dydrogesterone combination therapy provides significantly greater short-term reduction in perimenopausal symptoms than dydrogeste...

Regulatory News
See All
3170
Regulatory News

Etripamil nasal spray receives FDA approval for rapid relief of P...

FDA has approved intranasal etripamil for paroxysmal supraventricular tachycardia, delivering fast, on-demand restoration of normal heart rhythm....

6086
Regulatory News

FDA clears new oral therapy rilzabrutinib for treatment-resistant...

FDA approves rilzabrutinib tablets as a new oral treatment option for adults with persistent or chronic ITP who show insufficient response to sta...

4537
Regulatory News

FDA expands access to omalizumab therapy with first interchangeab...

The FDA has authorized omalizumab-igec as the first interchangeable biosimilar to omalizumab for treating asthma, urticaria, chronic rhinosinusit...

4427
Regulatory News

FDA introduces front-of-package nutrition labels to tackle chroni...

The FDA has proposed requisition of front-of-package nutrition labels on most packaged foods to clearly display levels of saturated fat, sodium,...

11585
Regulatory News

EMA issues flu vaccine composition guidance for 2025/2026 season

EMA recommends updated trivalent influenza vaccines for the 2025/2026 season, selecting strains based on global surveillance data and excluding B...

5556
Regulatory News

Reddy’s and Henlius collaborate to commercialize daratumumab bios...

Dr. Reddy’s has secured exclusive U.S. and Europe commercialization rights for Henlius’s daratumumab biosimilar HLX15 in a deal worth...

Try: